Literature DB >> 22198853

Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective.

Willem M Lijfering1, Linda E Flinterman, Jan P Vandenbroucke, Frits R Rosendaal, Suzanne C Cannegieter.   

Abstract

Venous thrombosis and arterial thrombosis are traditionally regarded as two different diseases with respect to pathophysiology, epidemiology, and treatment strategies. Research findings of the past few years suggest that this categorical distinction may be too strict. However, whether the described relationship between venous and arterial thrombosis is real or a result of other factors such as confounding, chance, or bias is still unclear. In this review, we discuss the current literature while using causal diagrams to better understand possible causal relations between cardiovascular risk factors, atherosclerosis, arterial thrombosis, and venous thrombosis. Furthermore, we propose study designs to investigate the causal link between venous and arterial thrombosis. In addition, we comment on the effect of statin use on the occurrence of both arterial and venous thrombosis. The possible clinical implications of these findings are discussed. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 22198853     DOI: 10.1055/s-0031-1297367

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  22 in total

Review 1.  Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 2.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 3.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

4.  Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Pamela L Lutsey; Vijay Nambi; Christopher R deFilippi; Susan R Heckbert; Mary Cushman; Christie M Ballantyne
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

Review 5.  Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?

Authors:  Ashish N Rao; Nayef M Kazzaz; Jason S Knight
Journal:  World J Cardiol       Date:  2015-12-26

6.  Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies.

Authors:  Michel K Barsoum; Kevin P Cohoon; Véronique L Roger; Ramila A Mehta; David O Hodge; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2014-07-05       Impact factor: 3.944

7.  Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Authors:  A R Folsom; P L Lutsey; S R Heckbert; K Poudel; S Basu; R C Hoogeveen; M Cushman; C M Ballantyne
Journal:  J Thromb Haemost       Date:  2018-08-11       Impact factor: 5.824

8.  Elevated prothrombin promotes venous, but not arterial, thrombosis in mice.

Authors:  Maria M Aleman; Bethany L Walton; James R Byrnes; Jian-Guo Wang; Matthew J Heisler; Kellie R Machlus; Brian C Cooley; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-30       Impact factor: 8.311

9.  Inflammatory plasma markers and risk for venous thromboembolism.

Authors:  Signy V Sveinsdottir; Peter J Svensson; Gunnar Engström
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

10.  Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study.

Authors:  Morten Schmidt; Sigrun A Johannesdottir; Stanley Lemeshow; Timothy L Lash; Sinna P Ulrichsen; Hans Erik Bøtker; Henrik Toft Sørensen
Journal:  BMJ Open       Date:  2013-04-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.